Novo Nordisk A/S Common Stock (NVO)

Income Tax Expense

kr 5.89B

Quarterly · Period ending: · DKK

NVO logo

NVO Income Tax Expense

Latest reportedkr 5.89B DKK
NVO Quarterly Income Tax · DKK (kr 0.00 → kr 5.89B)
High-resolution chart · PNG

NVO income tax expense history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Income Tax Expense — Quarterly (DKK)
Period endingIncome Tax Expense (DKK)
5,886,000,000
13,615,000,000
7,294,000,000
5,511,000,000
7,302,000,000
7,999,000,000
7,327,000,000
7,083,000,000
5,282,000,000
6,511,000,000
5,657,000,000
5,585,000,000
4,826,000,000
4,923,000,000
2,724,000,000
3,627,000,000
3,477,000,000
3,709,000,000
2,221,000,000
2,993,000,000
2,794,000,000
3,315,000,000
2,684,000,000
2,393,000,000
2,791,000,000
3,124,000,000
2,362,000,000
1,913,000,000
2,550,000,000
2,777,000,000
1,873,000,000
2,101,000,000
2,155,000,000
2,858,000,000
2,318,000,000
2,692,000,000
2,692,000,000
2,848,000,000
2,243,000,000
2,498,000,000
2,634,000,000
2,498,000,000
2,056,000,000
1,753,000,000
2,205,000,000
2,609,000,000
1,823,000,000
1,954,000,000
1,995,000,000
1,843,000,000
1,737,000,000
1,884,000,000
1,947,000,000
1,787,000,000
1,697,000,000
1,692,000,000
1,597,000,000
1,393,000,000
1,122,000,000
1,255,000,000
1,234,000,000
1,217,000,000
759,000,000
1,071,000,000
1,060,000,000
993,000,000
669,000,000
852,000,000
893,000,000
806,000,000
750,970,000
842,000,000
781,985,000
688,000,000
375,926,200
673,780,000
742,615,000
664,137,000
682,995,000
758,779,000
747,213,000
517,117,000
484,453,000
663,732,000
658,526,000
557,489,000
681,175,000
610,408,000
633,723,000
525,653,000
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.